Avalo Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:C6K0 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Jun 23	Sell€2,282,349	Armistice Capital LLC	Company	18,396.06	€134.15
27 Jun 23	Sell€1,979,336	Armistice Capital LLC	Company	15,348.21	€134.15
26 Jun 23	Sell€944,056	Cambyz Golestaneh	Individual	6,700.05	€141.48
20 Jun 23	Buy€7,600	Cambyz Golestaneh	Individual	8.33	€911.99
16 Jun 23	Buy€21,379	Cambyz Golestaneh	Individual	25.67	€857.86
14 Jun 23	Buy€19,237	Cambyz Golestaneh	Individual	25	€769.49
13 Jun 23	Buy€39,587	Cambyz Golestaneh	Individual	45.41	€963.34
09 Jun 23	Buy€52,478	Cambyz Golestaneh	Individual	60.11	€924.44
09 Jun 23	Buy€12,720	Garry Neil	Individual	16.67	€763.17
09 Jun 23	Buy€1,625	Christopher Sullivan	Individual	2.13	€763.17
31 May 23	Buy€2,273	Cambyz Golestaneh	Individual	3.52	€646.30
30 May 23	Buy€6,962	Cambyz Golestaneh	Individual	11.13	€641.84
24 May 23	Buy€24,918	Cambyz Golestaneh	Individual	37.5	€670.62
22 May 23	Buy€82,750	Cambyz Golestaneh	Individual	110.92	€781.24
16 May 23	Buy€10,134	Cambyz Golestaneh	Individual	18.25	€607.66
08 May 23	Buy€62,955	Cambyz Golestaneh	Individual	104.17	€626.24

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of C6K0?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	209	0.0202%
Private Companies	60,112	5.81%
Institutions	64,616	6.25%
VC/PE Firms	112,834	10.9%
General Public	796,359	77%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 1780.2%.

Top Shareholders

Top 24 shareholders own 22.99% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.9%	Deep Track Capital, LP	112,834	€1.8m	0%	0.06%
5.64%	Emerald Bioventures, Llc	58,346	€936.3k	0%	no data
4.07%	Nantahala Capital Management, LLC	42,100	€675.6k	0%	0.07%
1.54%	BlackRock, Inc.	15,876	€254.8k	3,540%	no data
0.45%	Natixis, Investment Banking and Corporate Banking Investments	4,604	€73.9k	0%	no data
0.17%	Tower Research Capital LLC	1,766	€28.3k	753%	no data
0.054%	Geode Capital Management, LLC	556	€8.9k	0%	no data
0.05%	FNY Investment Advisers, LLC	522	€8.4k	0%	0.01%
0.037%	The Vanguard Group, Inc.	382	€6.1k	0%	no data
0.033%	BCV Asset Management	338	€5.4k	0%	no data
0.014%	Steven Boyd	143	€2.3k	0%	no data
0.013%	Royal Bank of Canada, Banking & Securities Investments	138	€2.2k	13,700%	no data
0.0058%	Garry Neil	60	€962.5	9.09%	no data
0.0043%	Morgan Stanley, Investment Banking and Brokerage Investments	44	€705.3	2.33%	no data
0.0033%	BBVA Asset Management, S.A., S.G.I.I.C	34	€546.0	0%	no data
0.00068%	Wells Fargo & Company, Private Banking and Investment Banking Arm	7	€112.8	600%	no data
0.00058%	Lord, Abbett & Co. LLC	6	€96.2	0%	no data
0.00058%	Christopher Sullivan	6	€96.2	20%	no data
0.00019%	UBS Asset Management AG	2	€31.5	100%	no data
0.00019%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	2	€31.5	0%	no data
0.00019%	Group One Trading LP, Asset Management Arm	2	€31.5	100%	no data
0.0001%	Guggenheim Partners, LLC	1	€16.6	0%	no data
0.0001%	Wells Fargo & Company, Securities and Brokerage Investments	1	€16.6	-75%	no data
0.0001%	Advisor Group Holdings, Inc., Asset Management Arm	1	€16.6	0%	no data